Kissei Pharmaceutical Partners With Reborna Biosciences for Drug Discovery in Genetic Rare Diseases
Kissei Pharmaceutical Partners With Reborna Biosciences for Drug Discovery in Genetic Rare Diseases
基生藥品與Reborna生命科學合作，在遺傳性罕見疾病的藥物發現領域。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間